AZN vs ELA · P/E 28, $288.38B cap vs P/E 21, rev $155.2M
AstraZeneca PLC (AZN) versus Envela Corp (ELA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Envela Corp (ELA) is a luxury goods company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Not investment advice. Open the AZN and ELA stock pages for the full models.
Not investment advice.